|
Age adjusted mean values and proportions by height |
Simple correlation analysis of height and other variables |
Height Quartile |
Q1 (low) |
Q2 |
Q3 |
Q4 (High) |
P for trend |
r |
p |
Median Height level, cm |
154.6 |
159.7 |
163.9 |
169.0 |
|
|
Number |
197 |
196 |
197 |
197 |
|
2587 |
Age, years |
73.1 ± 6.9 |
71.5 ± 7.0 |
69.4 ± 6.2 |
68.0 ± 6.2 |
<0.001 |
-0.296 |
<0.001 |
Systolic blood pressure, mmHg |
144 |
142 |
140 |
142 |
0.229 |
-0.065 |
0.068 |
Diastolic blood pressure, mmHg |
83 |
83 |
82 |
84 |
0.254 |
0.086 |
0.015 |
Antihypertensive medication use, % |
29.1 |
35.7 |
29.0 |
34.7 |
0.312 |
-0.025 |
0.488 |
Antidiabetic medication use, % |
5.3 |
5.5 |
8.7 |
8.9 |
0.367 |
0.047 |
0.187 |
Lipid lowering medication use, % |
5.4 |
6.1 |
3.6 |
7.3 |
0.462 |
0.017 |
0.634 |
History of cardiovascular disease, % |
9.0 |
14.0 |
13.1 |
11.2 |
0.436 |
-0.016 |
0.649 |
Body mass Index, Kg/m2 |
22.0 |
21.9 |
21.8 |
21.9 |
0.836 |
-0.016 |
0.363 |
Current drinkers, % |
42.2 |
46.2 |
51.9 |
55.3 |
0.057 |
0.140 |
<0.001 |
Current smokers, % |
22 |
25 |
19 |
22 |
0.635 |
0.009 |
0.791 |
HbA1c (NGSP), % |
5.7 |
5.9 |
5.9 |
6.2 |
0.012 |
0.012 |
0.730 |
Serum HDL-Cholesterol, mg/dL |
56 |
56 |
58 |
55 |
0.093 |
0.009 |
0.795 |
Serum triglycerides (TG), mg/dL |
112 |
105 |
107 |
112 |
0.707 |
0.038 |
0.278 |
Serum aspartate aminotranferase (AST) IU/L |
25 |
25 |
25 |
24 |
0.384 |
-0.071 |
0.045 |
Serum uric acid, mg/dL |
5.7 |
5.9 |
5.9 |
6.2 |
0.012 |
0.128 |
<0.001 |
Serum creatinine, mg/dL |
0.87 |
0.89 |
0.91 |
0.97 |
0.002 |
0.119 |
<0.001 |
Age: Mean ± Standard Deviation, P: P value, NGSP: National Glycohemoglobin Standardization Program, Height quartile: <157.9cm, l57.9-l61.7cm, 161.8-165.7 cm and
>l65.7 cm. |